Elliott H. Sohn

Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial

Stephen R. Russell, Jean Bennett, Jennifer Wellman et al. · The Lancet · 2017 · 1.8K citations · Full text

Ocular Disease, Retina, Ophthalmology +6

Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus

Elliott H. Sohn, Hille W. van Dijk, Chunhua Jiao et al. · Proceedings of the National Academy of Sciences · 2016 · 637 citations · Full text

Ocular Disease, Retinal Neurodegeneration, Retinal Therapies +16

Paracentral Acute Middle Maculopathy

David Sarraf, Ehsan Rahimy, Amani A. Fawzi et al. · JAMA Ophthalmology · 2013 · 448 citations

Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab

Benjamin Bakall, James C. Folk, H. Culver Boldt et al. · American Journal of Ophthalmology · 2013 · 226 citations

Ocular Disease, Aflibercept Therapy, Ophthalmology +6

The Membrane Attack Complex in Aging Human Choriocapillaris

Robert F. Mullins, Desi P. Schoo, Elliott H. Sohn et al. · American Journal Of Pathology · 2014 · 221 citations · Full text